Insiders · CALA

Blake Wise

Director at Calithera Biosciences, Inc. (CALA)

Blake Wise has filed 2 insider reports with the SEC since June 2021, as director at Calithera Biosciences, Inc. (CALA). The latest filing, on June 3, 2022, reports grant or award at Calithera Biosciences, Inc. (CALA).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Blake Wise is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Calithera Biosciences, Inc. logo
CALA
Calithera Biosciences, Inc.
DirectorJun 3, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Blake Wise with

Questions about Blake Wise

What is Blake Wise's role at Calithera Biosciences, Inc.?
Blake Wise reports to the SEC as director at Calithera Biosciences, Inc. (CALA), according to the latest filing on June 3, 2022.
Has Blake Wise bought or sold stock recently?
No open-market purchases or sales by Blake Wise are on file. The filings report grant or award.
How do I get alerts when Blake Wise files?
Follow Blake Wise on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Blake Wise (SEC CIK 0001654446). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR